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Adult rats were intracraneally injected with [32P] 
phosphate and brain microtubules isolated. The elec- 
trophoretically purified, in viva phospholabeled, &tu- 
bulin was digested with the VS-protease and the la- 
beled peptide purified by reversed-phase liquid chro- 
matography. Its amino acid sequence corresponds to 
the COOH-terminal sequence of a minor neuronal fl3- 
tubulin isoform from chicken and human. The phos- 
phorylation site was at serine 444. A synthetic peptide 
with sequence EMYEDDEEESESQGPK, correspond- 
ing to that of the COOH terminus of /33-tubulin, was 
efficiently phosphorylated in vitro by casein kinase II 
at the same serine 444. 
The functional meaning of tubulin phosphorylation 
is still unclear. However, the modification of the pro- 
tein takes place after microtubule assembly, and phos- 
phorylated tubulin is mainly present in the assembled 
microtubule protein fraction. 
The existence of a number of different isoelectric forms of 
LY- and fi-tubulin subunits (l), greater than the actual number 
of tubulin genes (Z-4), suggests that tubulin heterogeneity is 
probably due in part to posttranslational modifications of this 
protein. One of these modifications is phosphorylation. The 
in uiuo phosphorylation of the P-tubulin subunit in differen- 
tiated neuroblastoma cells has been demonstrated (5-S); it 
occurs mainly on a serine residue in a specific fi-tubulin 
isoform (5-7) and is correlated with an increased assembly of 
microtubules during neurite outgrowth (5). More recently, it 
has been shown that the phosphorylation of p-tubulin found 
in neuroblastoma cells is possibly due to the action of a casein 
kinase II-related enzyme (8). Using tryptic and CNBr cleav- 
age, it was demonstrated that the phosphorylated residue is 
located close to the carboxyl terminus (8). These results are 
compatible with two possibilities: either the phosphorylation 
takes place on serine 413 in the major constitutive p1 isoform, 
or on serines 444 and/or 446 in the minor neural p3 isotubulin 
(see the nomenclature of Cleveland (2), or ps in the nomen- 
clature of Cowan et al. (9)). It has recently been suggested 
that a /3-tubulin isoform, which probably corresponds to p3- 
tubulin, is that phosphorylated in neuroblastoma cells (10). 
In this study, we have isolated in viva phosphorylated p- 
tubulin from rat brain and localized the modified residue at 
serine 444 of the minor neural &isotubulin. A synthetic 
peptide, corresponding to the COOH terminus of &tubulin, 
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is also efficiently phosphorylated in uitro by casein kinase II 
at serine 444. Finally, it was found that phosphorylated tu- 
bulin is mainly present in the assembled microtubule fraction. 
EXPERIMENTAL PROCEDURES 
Materials-Antibody against @-tubulin subunit was obtained from 
Amersham Corp (United Kingdom). Antibody to Pa-tubulin was ob- 
tained using a synthetic peptide containing the carboxyl-terminal 
sequence of &tubulin as immunogen.’ Antibody against acetylated 
tubulin was a kind gift of Dr. Piperno, Rockefeller University. Taxol 
was a kind gift from N. R. Lomax at the National Institutes of Health. 
Y-Protein A from Staphylococcus aureuS was obtained from Amer- 
sham Corp. (United Kingdom). 
Purification of Protein-Casein kinase II was purified from rat 
brain and assayed following the method of Meggio et al. (11). 
The isolation of microtubule protein and of tubulin depleted of 
associated proteins has also been previously detailed (8, 12). 
Cell Culture, Labeling, Extraction, and Zmmunoblotting-N115 
mouse neuroblastoma cells were grown in Dulbecco’s modified Eagle’s 
medium supplemented with 10% fetal calf serum and induced to 
differentiate by transfer to serum-free Dulbecco’s modified Eagle’s 
medium for 10 days. The cells were then washed with Dulbecco’s 
modified Eagle’s medium containing one-tenth the normal phosphate 
concentration and incubated overnight in the same medium, to which 
500 &/ml 32P04 (HCl and carrier-free) (Amersham Corp.) had been 
added. 
After the incubation with labeled phosphate, the cells were washed 
with 10 mM phosphate buffer, pH 7.0, 0.15 M NaCl. Soluble and 
assembled tubulin fractions were extracted in situ from N115 neuro- 
blastoma cells following the procedure of Black et al. (13), with slight 
modifications. Briefly, cells attached to culture dishes were perme- 
abilized by adding a buffer containing 0.1 M PIPES,’ pH 6.9, 0.25% 
(w/v) Triton X-100, 2 M glycerol, 1 mM MgCl,, 2.5 mM EGTA, 10 
rg/ml aprotinin, 10 fig/ml pepstatin A, 10 *g/ml leupeptin, 1 mM 
PMSF, 20 mM NaF, and 1 mM ATP. The soluble protein fraction 
obtained after incubation in this buffer includes unassembled micro- 
tubule protein, whereas assembled microtubule protein largely parti- 
tions with the detergent-insoluble protein fraction. The latter fraction 
can be extracted by resuspension of the cells in 0.1 M PIPES, pH 6.9, 
containing 6 mM CaCl*, 10 pg/ml aprotinin, 10 @g/ml pepstatin A, 10 
pg/ml leupeptin, 1 mM PMSF, 20 mM NaF, and incubation for 30 
min at 0 “C. The extracted protein was isolated in the supernatant 
after centrifugation for 15 min at 20,000 X g at 2 “C. The cold/ 
calcium-insoluble fraction was resuspended in 20 mM Tris-HCl, pH 
7.0, containing 1% sodium dodecyl sulfate and 2% P-mercaptoethanol. 
Aliquots of these fractions were characterized by gel electrophoresis. 
Following electrophoresis, the proteins were either stained in the gel 
with Coomassie Blue or blotted onto nitrocellulose paper (14), to be 
incubated with anti-P-tub&n and anti-&tubulin antibodies. 
To measure the amount of assembled tubulin, the above microtu- 
bule fractions, separated by electrophoresis and blotted onto paper, 
were first incubated with a monoclonal antibody against P-tubulin 
and subsequently with a polyclonal antibody to mouse IgGs raised in 
rabbit and S. oUrelLs protein A labeled with ““-iodine (Amersham 
Corp.). The amount of tubulin present in each fraction was calculated 
’ J. E. Dominguez, manuscript in preparation. 
’ The abbreviations used are: PIPES, 1,4-piperazinediethanesul- 
fonic acid; EGTA, [ethylenebis(oxyethylenenitrilo)]tetraacetic acid; 
PMSF, phenylmethylsulfonyl fluoride; MES, 4-morpholineethane- 
sulfonic acid; HPLC, high performance liquid chromatography; 
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to be proportional to the number of “‘1 cpm measured in that fraction. 
In Viva Phosphorylation and Isolation of Tubulin Phosphopepptide- 
Thirty-day-old rats were anesthetized and received intracraneal in- 
jections of 1 mCi of [“‘PIphosphate (Amersham Corp., 40 mCi/ml). 
After 12 h, rats were killed and the brains collected. Microtubule 
protein was then prepared as previously described (12), using 10 pM 
taxol to promote assembly in the presence of 1 mM GTP, 1 mM ATP, 
20 mM NaF, 1 mM PMSF, 10 pg/ml aprotinin, 10 pg/ml pepstatin A, 
and 10 Kg/ml leupeptin. The polymerized fraction was isolated after 
centrifugation through a cushion of 40% (w/v) sucrose in buffer A 
(0.1 M MES, pH 6.4, 2 mM EGTA, 0.5 mM MgClJ. The resulting 
pellet was washed in buffer A containing 1 mM GTP, 1 mM ATP, 1 
mM PMSF, 20 mM NaF, and 1 M NaCl to decrease the proportion of 
microtubule-associated proteins in the polymer. The polymerized 
protein was electrophoresed under the conditions of Laemmli on 7.5% 
polyacrylamide gels (15). The dried gel was autoradiographed and the 
labeled fl-tubulin band excised and extensively digested with S. aureus 
V8 protease (3% (w/v) for 24 h at 37 “C) in 50 mM NHIHCOJ, pH 
8.0 (16). The resulting peptides were lyophylized and dissolved in 
0.1% (v/v) trifluoroacetic acid. They were then loaded onto a reverse- 
phase HPLC column (NOVAPACK C-3 and fractionated using 
different O-100% acetonitrile gradients (see legends to the figures), 
with a flow rate of 0.5 ml/min. Fractions (0.5 ml) were collected and 
the associated radioactivity determined by liquid scintillation count- 
ing (Cerenkov radiation). Phosphoamino-acid analysis was performed 








FIG. 1. In uivo phosphorylation of rat brain tubulin. a, rats 
were intracraneally injected with “*PO, and brain microtubules puri- 
fied as indicated under “Experimental Procedures.” Microtubules 
were subjected to sodium dodecyl sulfate-polyacrylamide gel electro- 
phoresis in a 6.5% polyacrylamide gel containing 2 M urea, and the 
Coomassie Blue staining of the gel (C) and the corresponding auto- 
radiography (A) are shown. Both high molecular weight MAPS and 
/3-tubulin are phosphorylated. b, phosphoamino acid analysis of phos- 
In Vitro Phosphorylation Assays of Synthetic Peptides-Peptides 
were synthesized on an automatic solid-phase peptide synthesizer 
(type 430A, Applied Biosystems) (Foster City, CA) and purified by photubulin. 
reverse-phase HPLC on a NOVAPAK C-,8 column, using a Waters 
501 apparatus. The peptides were lyophilized and dissolved in 0.1 M 
PIPES, pH 6.9,2 mM EGTA, 5 mM MgCl*, and 1 mM PMSF. 
Kinase assays were performed in a final volume of 0.1 ml containing 
1 mM peptide and 1 mM [r-“‘P]ATP, except where indicated. The 
samples were incubated at 30 “C and reactions terminated by adding 
1 M HCl. After heating the sample for 5 min in a boiling water bath, 
an equal volume of 0.1% trifluoroacetic acid was added. The sample 
was then applied to a NOVAPAK C-ls column equilibrated with 0.1% 
trifluoroacetic acid. The column was extensively washed with 0.1% Ol- 
trifluoroacetic acid, and the peptide was then eluted with an aceto- 
nitrile gradient. The peptide-associated radioactivity was determined 
by liquid scintillation counting or by Cerenkov radiation. Samples 02- 
containing only casein kinase II plus ATP were used to determine L 
the background. Counts obtained from blank samples were sub- P 
stracted from those obtained when the peptide was present. 
In vitro phosphorylation of tubulin by casein kinase II was per- 
Ol- 
formed as previously indicated (8). 
Other Protein-Chemical Procedures-Thin layer electrophoresis 
was carried out on cellulose plates (Cel300, Merck Darmstadt Federal I 
Republic of Germany), using 10% pyridine, 0.5% acetic acid, pH 6.3, 0 
as running buffer. Autoradiography was performed using Kodak XR 
film with 48-h exposure times. 
1 10 
20 LO 60 IO 
Peptides were sequenced with an Applied Biosystems gas-phase 
sequenator (model 470A) equipped with an on-line phenylthiohydan- 
toin amino acid analyzer (model 120 A). 
RESULTS 
To characterize brain phosphotubulin, an intracraneal in- 
jection of [32P]phosphate into an adult rat was performed. 
Twelve h after injection, microtubules were isolated, in the 
presence of taxol and salt, to obtain a preparation of assem- 
bled tubulin with a low proportion of microtubule-associated 
proteins (MAPS). Fig. 1 shows that only @-tubulin and high 
molecular weight MAPS were phosphorylated. Phosphoamino 
acid analysis of the P-tubulin yielded only labeled phospho- 
serine (Fig. lb). To localize the phosphorylated site, the 
labeled /3-tubulin was subjected to an exhaustive S. aureuS V8 
protease digestion, and the proteolytic fragments were puri- 
fied by reverse-phase HPLC. The peptide pattern obtained 
(Fig. 24 reveals the presence of one major phosphopeptide. 
Since this peptide eluted close to other unlabeled peptides 
which could contaminate it, the phosphopeptide was further 
subjected to HPLC fractionation using different gradient 




FIG. 2. HPLC analysis of @-tubulin peptides. A, phosphoryl- 
ated /3-tubulin band was cut out of the gel, extensively digested with 
S. aureus V8 protease, and run on an HPLC column, as described 
under “Experimental Procedures.” Peptides were eluted with the 
gradient indicated in the figure at a flow rate of 0.5 ml/min. Absorb- 
ance at 215 nm (continuous line) and radioactive counts (discontin- 
uous line) are plotted against elution time. B, HPLC chromatography 
of the fl-tubulin phosphopeptide obtained after a second proteolytic 
digestion and fractionated with the acetonitrile gradient (in 0.1% 
trifluoroacetic acid) indicated in the figure at a flow rate of 0.5 ml/ 
min. Absorbance at 215 nm (continuous line) and radioactive counts 
(discontinuous line) are plotted against elution time. 
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subjected to amino acid sequence analysis. 
The derived peptide sequence MYEDDEEEXE matches 
the COOH-terminal sequence EMYEDDEEESESQGPK- 
COOH of the minor neural ,& isoform of chick and human 
tubulin, as predicted from the corresponding cDNA clones 
(2). It is known that phosphoserine (when not modified, see 
for instance Ref. 18) is dephosphorylated and destroyed when 
removed from the peptide chain in the course of Edman 
degradation, thus producing a gap during sequence analysis. 
As it has previously been established that a P-tubulin isoform 
was phosphorylated at serine (see above), we conclude that 
the missing residue corresponding to site 444 in the &tubulin 
sequence is the phosphorylated serine. 
The cDNA sequence encoding /33-tubulin has been deter- 
mined in human, mouse, and chicken (2, 9). Different amino 
acids are found at residue 446: serine in human, arginine in 
mouse and a gap in chicken. It is not known which amino 
acid is present at position 446 in rat, but it does not seem to 
be phosphoserine, as a second phosphorylated peptide was 
not detected in our analyses. However, we cannot completely 
rule out that a presumptive serine 446 may be present adjacent 
to the COOH-terminal residue of the peptide MYED- 
DEEEXE in rat, due to an unspecific cleavage by the V8 
protease after phosphorylated residues. If this is the case, this 
serine would have escaped our analyses, as a COOH-terminal 
phosphoserine would be undetectable by gas-phase sequenc- 
ing. To address this problem, in addition to confirming the 
results of in vivo phosphorylation by in vitro assays, we 
synthesized a peptide corresponding to the COOH terminus 
of human /33-tubulin, EMYEDDEEESESQGPK, and phos- 
phorylated it in vitro. A second peptide corresponding to the 
region 408-428 (FTEAESNMNDLUSEYQQYQDA) of the 
major /3-tubulin isoform(s), which contained another pre- 
sumptive serine phosphorylation site, was used for compari- 
son. In vitro phosphorylation was carried out using casein 
kinase II, as this protein kinase shows the same tubulin 
phosphorylation pattern as that found in neuroblastoma cells 
(8). Fig. 3 shows that the &tubulin peptide incorporates more 
phosphate after incubation with ATP and casein kinase II 
than the other peptide. Fig. 3 also indicates an incorporation 
of approximately 1.3 mol of phosphate/m01 of the tubulin 
I 2 3 
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FIG. 3. Kinetics of the in vitro phosphorylation of /3-tubulin 
peptides by purified casein kinase II. Shown is the time course 
of phosphorylation for the synthetic peptide (residues 435-450) from 
the minor neuronal &tubulin isoform (solid circles) or that (residues 
408-428) from the ubiquitous Pi-tubulin isoform (open circles) when 
phosphorylated by casein kinase II in the presence of 10 mM ATP. 
Standard deviations are indicated by bars. Inset shows the determi- 
nation of the moles of phosphate incorporated into the synthetic 
peptide from the minor neuronal &-tubulin isoform at different ATP 
concentrations. 
peptide containing the COOH terminus of the minor neural 
isoform. Peptide phosphorylation was further tested by iso- 
lation of the phosphopeptide on thin layer electrophoresis at 
pH 6.5, followed by autoradiography (Fig. 4~). This showed 
one major spot corresponding to 32P-labeled peptide, which is 
consistent with the modification of a single residuelpeptide. 
This 32P-peptide was then digested with the V8 protease and 
the obtained mixture was separated again by electrophoresis 
at pH 6.5 (Fig. 4b). A new spot with a higher electrophoretic 
mobility was now observed, which corresponded to a peptide 
with the sequence MYEDDEEEXE. This peptide also comi- 
grated with the in vivo phospholabeled peptide in both the 
electrophoretic and HPLC analyses (results not shown). The 
second peptide released by V8 protease digestion was an 
unlabeled basic peptide with the sequence SQGPK. 
These data are consistent with the phosphorylation of a 
single serine residue, corresponding to position 444 in /33- 
tubulin. A similar result was obtained when the phosphoryl- 
ation of tubulin in differentiated neuroblastoma cells was 
analyzed. In mouse neuroblastoma N115 cells, tubulin was 
also phosphorylated in position 444 of P3-tubulin, as deter- 
mined by sequencing the tubulin phosphopeptide isolated 
from differentiated cells after digestion with S. aureu.s V8 
protease. The amino-terminal sequence of this peptide is 
MYEDDE, as that obtained from rat brain phosphotubulin. 
The functional consequences of the phosphorylation of /33- 
tubulin are not known, although it has been observed that 
phosphorylation of /3-tubulin takes place after neurite exten- 
sion onset in neuroblastoma cells (5, 7, 8, 10). Thus, neuro- 
blastoma cells could be a suitable model for analysis of the 
. 
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FIG. 4. Electrophoresis of the tubulin synthetic peptide 
phosphorylated in vitro by casein kinase II. The synthetic 
peptide EMYEDDEEESESQGPK was phosphorylated in vitro with 
casein kinase II as indicated under “Experimental Procedures,” in 
the presence of 0.1 mM ATP. The phosphopeptide was further incu- 
bated in the absence (a) or presence (b) of S. aureus V8 protease and 
the labeled peptides subjected to thin layer electrophoresis in pH 6.3 
buffer (10% pyridine, 0.5% acetic acid), followed by autoradiography, 
that is shown in the figure. To trace the electrophoretic mobility from 
the origin (0), orange G was used. The electrophoresis was stopped 
when the marker reached the position indicated by the circled dixon- 
tinuous line. The major spot marked in lone a corresponds to the 
phosphorylated synthetic peptide. The minor spot with a lower elec- 
trophoretic mobility which is also found in lane a corresponds to a 
peptide lacking the amino-terminal glutamate residue of the synthetic 
peptide as a consequence of a low yield in the last step of the synthesis 
procedure. The spots marked in lane b were subjected to gas-phase 
sequencing as indicated in the text. 
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consequences of this posttranslational modification. In a pi- 
oneer work, Gard and Kirschner (5) found that tubulin mod- 
ification probably occurs after the assembly of tubulin into 
microtubules, since drugs which prevent microtubule assem- 
bly also prevent tubulin phosphorylation. A similar conclusion 
may be reached from the result of the experiment indicated 
in Fig. 5. This figure shows that the kinetics of tubulin 
phosphorylation was delayed with respect to that of the net 
microtubule assembly which takes place during neurite exten- 
sion in differentiated neuroblastoma cells. This result agrees 
with Gard and Kirschner’s report (5) and suggests that polym- 
erized tubulin could be a better substrate for the kinase 
involved in its phosphorylation than nonpolymerized tubulin. 
To test for this possibility, the incorporation of phosphate 
into tubulin at different concentrations was measured in two 
fractions in which tubulin is assembled to a different extent. 
Fig. 6A shows a slightly lower Km (0.010 > p > 0.005) for the 
tubulin fraction with a higher proportion of polymerized 
protein with casein kinase II (the enzyme which phosphoryl- 
ates tubulin in a manner similar to that found in vivo (8)). 
However, the number of moles of phosphate incorporated into 
tubulin was the same for both tubulin fractions (Fig. 6B). 
To test for the in situ distribution of phosphorylated tubulin 
inside the cell, differentiated neuroblastoma cells were used. 
Cells were permeabilized with a nonionic detergent in a buffer 
which stabilizes polymerized microtubules and extracts un- 
assembled tubulin together with other soluble proteins, and 
subsequently in a microtubule-disrupting buffer containing 
calcium, which extracts the assembled tubulin. Fig. 7 shows 
the characterization of the protein extracted after incubation 
of differentiated neuroblastoma cells with both buffers and 
the distribution of phosphorylated /3-tubulin in the fractions 
containing assembled and unpolymerized tubulin. Fig. 7 in- 
dicates that phosphorylated tubulin is mainly present in the 
polymerized tubulin fraction inside the cell. This could be the 
consequence of a higher proportion of p3 isoform in the 
assembled fraction, whether it is phosphorylated or not. To 
analyze this point, the amount of p3 tubulin in the assembled 
and unassembled fractions was measured using an antibody 
which specifically recognizes the carboxyl-terminal region of 
&-tubulin. Fig. 8 indicates that the distribution of total p3- 
tubulin is different from that of phosphorylated &tubulin 
(compare the results of Figs. 7 and 8). As a control of the 
I I 
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FIG. 5. Increase in phosphorylation of @tubulin, microtu- 
bule assembly, and neurite extension during differentiation 
of N115 neuroblastoma cells. N115 neuroblastoma cells were 
labeled for 12 h with [32P]phosphate after O-14 days of serum with- 
drawal and the level of phosphorylated fl tubulin (U) (deter- 
mined after its isolation by gel electrophoresis by measuring the 
radioactivity associated with the protein band excised from the gel); 
the proportion of assembled microtubule protein (o---O) (deter- 
mined as indicated under “Experimental Procedures”), and the pro- 
portion of cells bearing neurites ([1--o) were measured and repre- 
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FIG. 6. Determination of the K,,, and moles of phosphate 
incorporated into assembled and unassembled tubulin by cas- 
ein kinase II. A, unassembled tubulin (0.5 mg/ml, conditions under 
which less than 5% tubulin is found assembled) or tubulin assembled 
in the presence of 10 pM taxol (0.5 mg/ml, conditions under which 
more than 90% tubulin is found assembled), were serially diluted and 
incubated with 4 pg of casein kinase II in the presence of lo-’ M [y- 
32P1ATP for 15 min at 35 “C. The reaction was stormed bv adding __ _ 
sample electrophoresis buffer and subjected to gel electrophoresis. 
The inverse of the amount of labeled phosphate incorporated into fi- 
tubulin of uersus the inverse of the tubulin concentration is repre- 
sented. The apparent K,,, for taxol-assembled tubulin is 10 + 2 pM, 
whereas that for unassembled tubulin is 17 -+ 3 gM. B, aliquots of 
taxol-assembled and unassembled tubulin (0,5 mg/ml) were incu- 
bated with 4 Fg of casein kinase II at various concentrations of ATP 
for 15 min at 30 “C. The reaction was stopped by adding sample 
electrophoresis buffer, and the samples were subjected to gel electro- 
phoresis. After electrophoresis, the @-tub&n peptide band was ex- 
cised, and its radioactivity was determined by measuring the Ceren- 
kov radiation. The figure shows the moles of phosphate incorporated/ 
mol of tubulin as a function of ATP concentration. Taxol-assembled 
tubulin is indicated by closed circles, and nonpolymerized tubulin by 
open circles. 
experiment of Fig. 8, the distribution of total P-tubulin using 
an antibody which recognizes a common epitope present in all 
p isoforms, and the distribution of acetylated a-tubulin (which 
is known to be mainly present in the assembled tubulin 
fraction (19)), were also tested. Fig. 8 shows that the distri- 
bution of total /3-tubulin is similar to that of &tubulin, while 
it differs from that of acetylated tubulin since this modified 
tubulin is almost only present in the polymerized fraction. 
These results could be explained by a preferential association 
of phosphorylated &tubulin with the assembled fraction or 
a preferential phosphorylation of the assembled p isoform. 
This latter possibility is supported by the fact that colcemide 
(and other depolymerizing drugs) abolish &tubulin phos- 
phorylation (5). 
DISCUSSION 
The major phosphorylation of brain tubulin takes place at 
its minor neural p3 isoform, as previously suggested for tubulin 
in neuroblastoma cells (7, 10). This minor neural tubulin 
isoform is only found in chordates (20,21), and its expression 
may be specifically associated with a class of neuronal cells 
appearing with the origin of the chordates. 
The in viuo and in vitro phosphorylation results indicate 
that the minor neural &tubulin isoform is modified at a 
A IBs P 
s P 
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Since the carboxyl terminus of tubulin contains the binding 
site for some microtubule-associated proteins (24, 25), it is 
interesting to know whether the phosphorylation of &tubulin 
might modulate the interaction of this tubulin isoform with 
MAPS or its ability to polymerize, in a similar way to that 
found for tubulin phosphorylated by calcium/calmodulin-de- 
pendent protein kinase II (26). However, it has been indicated 
that tubulin phosphorylated in vitro by casein kinase II re- 
mains associated with microtubules assembled in vitro (8), in 
contrast to tubulin phosphorylated by calmodulin kinase II 
(26). 1103rpm~911 llQLQcpnW.21 
J 
FIG. 7. Partitioning of tubulin between soluble and micro- 
tubule assembled fractions. Neuroblastoma N115 cells (10s) were 
allowed to differentiate for 10 days in the absence of serum and then 
incubated overnight with [“‘PIphosphate, as indicated under “Exper- 
imental Procedures.” Extracts containing soluble (5’) and microtu- 
bule-assembled (P) fractions were prepared. The extracts were di- 
vided in several aliquots and the protein present in one of these 
aliquots was characterized by electrophoresis in a 10% polyacrylamide 
gel followed by Coomassie staining of the fractionated peptides (A) 
or subjected to electrophoresis in a 6.5% polyacrylamide gel contain- 
ing 2 M urea and phosphorylation of tubulin was tested by autoradi- 
ography (B); the counts associated with b-tubulin were determined 
after cutting out the p-tubulin band (after its identification by im- 
munoblotting), and the values obtained from the gels containing the 
soluble (S) and polymerized (P) protein are indicated in parentheses 
(data represent mean values and standard deviations from five ex- 
periments). Whereas 9% of the p-tubulin radioactive counts are 
associated with the soluble fraction, 91% of the counts are associated 
with the polymerized fraction. 
Ab PT Ab fi3 Ab aacet. 
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FIG. 8. Partitioning of &tubulin between the soluble and 
assembled microtubule fractions. Differentiated neuroblastoma 
cells were processed as in Fig. 7 and, after gel electrophoresis, the 
proteins were blotted onto nitrocellulose paper. The paper was incu- 
bated with an antibody against fl-tubulin (A&W), an antibody against 
the carboxyl-terminal region of /&tubulin (Ab&) or a monoclonal 
antibody against acetylated cu-tubulin (Ah acct.). After the first 
incubation, the paper was incubated with a peroxidase-conjugated 
goat anti-mouse or goat anti-rabbit immunoglobulin (diluted l/1000, 
Tago) and developed with 4-chloronaphthol and hydrogen peroxide. 
The stained bands were then measured by densitometry. The propor- 
tions of each tubulin isotype present in soluble (S) and assembled 
microtubule (P) fractions are indicated in parentheses. 
The functional significance of the phosphorylation of serine 
444 of &-tubulin is still unknown, although this modification 
correlates well with neurite extension in neuroblastoma cells 
(5,8). As the phosphorylation of tubulin probably takes place 
after its association with microtubules, it may be thought that 
&tubulin phosphorylation might favor the stabilization of 
the microtubules constituting the axonal scaffolding. Alter- 
natively, &-tubulin may be phosphorylated after the selective 
stabilization of axonal microtubules. 
On the other hand, we cannot rule out the presence of other 
phosphorylation sites on brain tubulin by other protein 
kinases, in case these phosphorylation events inhibit the 
ability of tubulin to polymerize, as our procedure to isolate in 
uiuo phosphorylated tubulin from brain cytosol is based on its 
in vitro assembly. For example, it has been described that 
brain tubulin phosphorylated in vitro by Ca/calmodulin-de- 
pendent protein kinase II cannot assemble into microtubules 
(26). This phosphorylation occurs on serine and threonine 
residues within the carboxyl terminus of tubulin (26), which 
are different from the serine phosphorylated by casein kinase 
II (8) now identified as residue 444 of the p3 isoform. Fur- 
thermore, tubulin phosphorylated in uitro by calmodulin ki- 
nase II may become associated with phospholipids (27). In 
view of the presence of tubulin in some membranous organ- 
elles including coated vesicles (28), it will be of interest to 
determine whether calmodulin-dependent phosphorylation of 
tubulin occurs in uiuo and results in the association of the 
phosphorylated tubulin with these organelles. 
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